Intellectual Property and Licensing in Biotech 2011

For biotech ideas to be successful, the idea must be protected by an IP strategy that supports financing and partnering and that results in an IP portfolio that provides sufficient exclusivity to ensure a good return on investment. SMi Group provides a CPD accredited masterclass which helps delegates and their firms ensure IP success by enabling professionals to discuss the challenges and develop strategies for them.

Benefits of attending:

• Analyse the specifics of developing a secure biotech IP strategy
• Discuss in scenario driven sessions successful approaches
• Debate case studies involving IP evolution, cost effectiveness and business models
• Utilise expert advice on IP and strategic partnering
• Gain valuable CPD points through attendance
• Learn from an extremely experienced Masterclass leader with over a decade of experience in IP and pharmaceuticals

For further information and the opportunity to register, please visit the website. Alternatively, contact Mo Saffaf on +44 (0) 20 7827 6022 or Email: [email protected]